Virtual Neuro-Oncology Tumor Board

MUSC Health’s Brain & Spine Tumor Program is a multidisciplinary collaboration among neurosciences, radiation oncology, neuroimaging, neuropathology and Hollings Cancer Center, South Carolina’s only National Cancer Institute-designated cancer center.

The program is committed to delivering the highest level of neuro-oncology care through a dedicated and experienced team focused on providing the most effective therapies. These efforts are backed by state-of-the-art facilities, cutting-edge technology, and breakthrough laboratory research.

Over the years, the Brain & Spine Tumor Program has expanded the types of tumors treated through advances in medical and surgical therapies, and a broadened array of clinical trials. As a result, South Carolinians and patients throughout the Southeast have access to extraordinary neuro-oncology services close to home.

The Tumor Board

Brain cancer is associated with significant morbidity and mortality. There are over 120 types of brain tumors with glioblastoma being the most common adult, malignant primary brain tumor. The care of brain tumor patients requires input from multiple specialists, ranging from neurosurgeons to radiation oncologists, neuro-oncologists, neuropathologists, and neuro-radiologists.

The Virtual Neuro-oncology Tumor Board provides specialty consultation remotely for patients with brain tumors. The patient will receive the benefit of a multi-specialty consultation provided by the MUSC Health Brain and Spine Tumor team. Information transmitted to and from MUSC occurs using a secure internet connection. Each new case is reviewed in detail and a consensus opinion is formed, further evaluation is recommended, and follow-up is scheduled as needed. The goal of the virtual tumor board is to provide comprehensive, state-of-the-art brain tumor care for all South Carolinians.

Submitting a Case

Please contact Mike Balassone at 843-792-6696 for clarification or if you experience any difficulties during this process. All relevant imaging studies should be included when submitting a case. If you have not been activated by the team, you will not be able to submit a case.

You will be emailed a date and time for your patient to be presented at MUSC's Virtual Neuro-oncology Tumor Board. On that date, please join the live meeting by logging into WebEx (link will be provided with your invitation).